Literature DB >> 11689613

Requirement of cysteines and length of the human respiratory syncytial virus M2-1 protein for protein function and virus viability.

R S Tang1, N Nguyen, X Cheng, H Jin.   

Abstract

The M2-1 protein of human respiratory syncytial virus (hRSV) promotes processive RNA synthesis and readthrough at RSV gene junctions. It contains four highly conserved cysteines, three of which are located in the Cys(3)-His(1) motif at the N terminus of M2-1. Each of the four cysteines, at positions 7, 15, 21, and 96, in the M2-1 protein of hRSV A2 strain was individually replaced by glycines. When tested in an RSV minigenome replicon system using beta-galactosidase as a reporter gene, C7G, C15G, and C21G located in the Cys(3)-His(1) motif showed a significant reduction in processive RNA synthesis compared to wild-type (wt) M2-1. C96G, which lies outside the Cys(3)-His(1) motif, was fully functional in supporting processive RNA synthesis in vitro. Each of these cysteine substitutions was introduced into an infectious antigenomic cDNA clone derived from hRSV A2 strain. Except for C96G, which resulted in a viable virus, no viruses were recovered with mutations in the Cys(3)-His(1) motif. This indicates that the Cys(3)-His(1) motif is critical for M2-1 function and for RSV replication. The functional requirement of the C terminus of the M2-1 protein was examined by engineering premature stop codons that caused truncations of 17, 46, or 67 amino acids from the C terminus. A deletion of 46 or 67 amino acids abolished the synthesis of full-length beta-galactosidase mRNA and did not result in the recovery of viable viruses. However, a deletion of 17 amino acids from the C terminus of M2-1 reduced processive RNA synthesis in vitro and was well tolerated by RSV. Relocation of the M2-1 termination codon upstream of the M2-2 initiation codons did not significantly affect the expression of the M2-2 protein. Both rA2-Tr17 and rA2-C96G did not replicate as efficiently as wt rA2 in HEp-2 cells and was restricted in replication in the respiratory tracts of cotton rats.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689613      PMCID: PMC114718          DOI: 10.1128/JVI.75.23.11328-11335.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription.

Authors:  A Bermingham; P L Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Expression of the ORF-2 protein of the human respiratory syncytial virus M2 gene is initiated by a ribosomal termination-dependent reinitiation mechanism.

Authors:  G Ahmadian; J S Randhawa; A J Easton
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

3.  Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents.

Authors:  H Jin; X Cheng; H Z Zhou; S Li; A Seddiqui
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription.

Authors:  R Fearns; P L Collins
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

5.  The Cys(3)-His(1) motif of the respiratory syncytial virus M2-1 protein is essential for protein function.

Authors:  R W Hardy; G W Wertz
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.

Authors:  P F Wright; R A Karron; R B Belshe; J Thompson; J E Crowe; T G Boyce; L L Halburnt; G W Reed; S S Whitehead; E L Anderson; A E Wittek; R Casey; M Eichelberger; B Thumar; V B Randolph; S A Udem; R M Chanock; B R Murphy
Journal:  J Infect Dis       Date:  2000-09-22       Impact factor: 5.226

7.  A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes.

Authors:  S S Whitehead; C Y Firestone; P L Collins; B R Murphy
Journal:  Virology       Date:  1998-08-01       Impact factor: 3.616

8.  Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein.

Authors:  M N Teng; P L Collins
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Model for polymerase access to the overlapped L gene of respiratory syncytial virus.

Authors:  R Fearns; P L Collins
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV.

Authors:  H Jin; D Clarke; H Z Zhou; X Cheng; K Coelingh; M Bryant; S Li
Journal:  Virology       Date:  1998-11-10       Impact factor: 3.616

View more
  18 in total

Review 1.  New generation live vaccines against human respiratory syncytial virus designed by reverse genetics.

Authors:  Peter L Collins; Brian R Murphy
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein.

Authors:  Dongsheng Li; David A Jans; Phillip G Bardin; Jayesh Meanger; John Mills; Reena Ghildyal
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

3.  Overexpression of the M2-2 protein of respiratory syncytial virus inhibits viral replication.

Authors:  Xing Cheng; HyunJung Park; Helen Zhou; Hong Jin
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Zinc binding activity of human metapneumovirus M2-1 protein is indispensable for viral replication and pathogenesis in vivo.

Authors:  Hui Cai; Yu Zhang; Yuanmei Ma; Jing Sun; Xueya Liang; Jianrong Li
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

5.  Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins.

Authors:  David R Morcock; James A Thomas; Tracy D Gagliardi; Robert J Gorelick; J David Roser; Elena N Chertova; Julian W Bess; David E Ott; Quentin J Sattentau; Ines Frank; Melissa Pope; Jeffrey D Lifson; Louis E Henderson; Bruce J Crise
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.

Authors:  Michael Weik; Jens Modrof; Hans-Dieter Klenk; Stephan Becker; Elke Mühlberger
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity.

Authors:  Stephen W Mason; Erika Aberg; Carol Lawetz; Rachel DeLong; Paul Whitehead; Michel Liuzzi
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner.

Authors:  Thi-Lan Tran; Nathalie Castagné; Virginie Dubosclard; Sylvie Noinville; Emmanuelle Koch; Mohammed Moudjou; Céline Henry; Julie Bernard; Robert Paul Yeo; Jean-François Eléouët
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

9.  Identification of amino acids that are critical to the processivity function of respiratory syncytial virus M2-1 protein.

Authors:  Helen Zhou; Xing Cheng; Hong Jin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

10.  Inactivation of respiratory syncytial virus by zinc finger reactive compounds.

Authors:  Marina S Boukhvalova; Gregory A Prince; Jorge C G Blanco
Journal:  Virol J       Date:  2010-01-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.